Intravenous thrombolysis use before interhospital transfer for thrombectomy: a systematic review and meta-analysis.

IF 5.4 2区 医学 Q1 CLINICAL NEUROLOGY
Zixin Wang, Yun Chen, Jiamin Li, Boyi Yuan, Wan Wang, Jiameng Li, Qingfeng Ma
{"title":"Intravenous thrombolysis use before interhospital transfer for thrombectomy: a systematic review and meta-analysis.","authors":"Zixin Wang, Yun Chen, Jiamin Li, Boyi Yuan, Wan Wang, Jiameng Li, Qingfeng Ma","doi":"10.1007/s00415-026-14173-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Intravenous thrombolysis (IVT) before interhospital transfer for endovascular thrombectomy (EVT) in patients with large-vessel occlusion acute ischemic stroke (LVO-AIS) remains controversial. We aimed to evaluate the efficacy and safety of pre-transfer IVT in LVO-AIS patients who presented to primary stroke centers (PSCs) and required transfer to comprehensive stroke centers (CSCs) for EVT.</p><p><strong>Methods: </strong>We systematically searched PubMed, Embase, and ClinicalTrials.gov from inception to July 2, 2026. Studies comparing IVT versus no IVT prior to interhospital transfer for EVT in patients with LVO-AIS were included. Efficacy outcomes included the primary outcome of excellent functional outcome (modified Rankin Scale [mRS] 0-1 at 90 days), as well as secondary efficacy outcomes including good functional outcome (mRS 0-2 at 90 days), interhospital recanalization, and poor functional outcome (mRS 5-6). Safety outcomes included 90-day mortality, symptomatic intracranial hemorrhage (sICH), any intracranial hemorrhage (ICH), and parenchymal hematoma (PH). Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models, and adjusted estimates were synthesized using the generic inverse variance method.</p><p><strong>Results: </strong>Sixteen observational studies were included. Pre-transfer IVT was associated with significantly higher rates of excellent functional outcome (OR 1.72, 95% CI 1.47-2.01, p<0.00001), good functional outcome (OR 1.64, 95% CI 1.35-1.99, p<0.00001), and interhospital recanalization (OR 7.71, 95% CI 4.08-14.55, p<0.00001), as well as significantly lower risks of poor functional outcome (OR 0.65, 95% CI 0.54-0.79, p<0.0001) and 90-day mortality (OR 0.69, 95% CI 0.59-0.81, p<0.00001). No significant differences were observed between groups in the risks of sICH (OR 0.75, 95% CI 0.50-1.11, p=0.15), any ICH (OR 0.91, 95% CI 0.76-1.09, p=0.31), or PH (OR 1.43, 95% CI 0.88-2.33, p=0.15). In the adjusted analyses, the associations remained significant for excellent functional outcome (aOR 1.47, 95% CI 1.19-1.81, p=0.0004), good functional outcome (aOR 1.61, 95% CI 1.25-2.07, p=0.0002), interhospital recanalization (aOR 8.06, 95% CI 4.71-13.82, p<0.00001), and 90-day mortality (aOR 0.64, 95% CI 0.49-0.84, p=0.001). The magnitude and direction of associations were generally consistent with the unadjusted analyses.</p><p><strong>Conclusion: </strong>Among LVO-AIS patients requiring interhospital transfer from PSCs to CSCs for EVT, pre-transfer IVT was associated with improved functional outcomes and interhospital recanalization, without increasing hemorrhagic risk. These findings support pre-transfer IVT as an effective reperfusion strategy in resource‑limited settings where timely EVT is not immediately accessible.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 10","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00415-026-14173-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Intravenous thrombolysis (IVT) before interhospital transfer for endovascular thrombectomy (EVT) in patients with large-vessel occlusion acute ischemic stroke (LVO-AIS) remains controversial. We aimed to evaluate the efficacy and safety of pre-transfer IVT in LVO-AIS patients who presented to primary stroke centers (PSCs) and required transfer to comprehensive stroke centers (CSCs) for EVT.

Methods: We systematically searched PubMed, Embase, and ClinicalTrials.gov from inception to July 2, 2026. Studies comparing IVT versus no IVT prior to interhospital transfer for EVT in patients with LVO-AIS were included. Efficacy outcomes included the primary outcome of excellent functional outcome (modified Rankin Scale [mRS] 0-1 at 90 days), as well as secondary efficacy outcomes including good functional outcome (mRS 0-2 at 90 days), interhospital recanalization, and poor functional outcome (mRS 5-6). Safety outcomes included 90-day mortality, symptomatic intracranial hemorrhage (sICH), any intracranial hemorrhage (ICH), and parenchymal hematoma (PH). Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models, and adjusted estimates were synthesized using the generic inverse variance method.

Results: Sixteen observational studies were included. Pre-transfer IVT was associated with significantly higher rates of excellent functional outcome (OR 1.72, 95% CI 1.47-2.01, p<0.00001), good functional outcome (OR 1.64, 95% CI 1.35-1.99, p<0.00001), and interhospital recanalization (OR 7.71, 95% CI 4.08-14.55, p<0.00001), as well as significantly lower risks of poor functional outcome (OR 0.65, 95% CI 0.54-0.79, p<0.0001) and 90-day mortality (OR 0.69, 95% CI 0.59-0.81, p<0.00001). No significant differences were observed between groups in the risks of sICH (OR 0.75, 95% CI 0.50-1.11, p=0.15), any ICH (OR 0.91, 95% CI 0.76-1.09, p=0.31), or PH (OR 1.43, 95% CI 0.88-2.33, p=0.15). In the adjusted analyses, the associations remained significant for excellent functional outcome (aOR 1.47, 95% CI 1.19-1.81, p=0.0004), good functional outcome (aOR 1.61, 95% CI 1.25-2.07, p=0.0002), interhospital recanalization (aOR 8.06, 95% CI 4.71-13.82, p<0.00001), and 90-day mortality (aOR 0.64, 95% CI 0.49-0.84, p=0.001). The magnitude and direction of associations were generally consistent with the unadjusted analyses.

Conclusion: Among LVO-AIS patients requiring interhospital transfer from PSCs to CSCs for EVT, pre-transfer IVT was associated with improved functional outcomes and interhospital recanalization, without increasing hemorrhagic risk. These findings support pre-transfer IVT as an effective reperfusion strategy in resource‑limited settings where timely EVT is not immediately accessible.

院间转院取栓前静脉溶栓的使用:系统回顾和荟萃分析。
目的:大血管闭塞性急性缺血性脑卒中(LVO-AIS)患者院间转院前静脉溶栓(IVT)治疗血管内取栓(EVT)仍存在争议。我们的目的是评估在初级卒中中心(PSCs)就诊并需要转移到综合卒中中心(CSCs)进行EVT的LVO-AIS患者的转移前IVT的有效性和安全性。方法:系统地检索PubMed、Embase和ClinicalTrials.gov,检索时间为2026年7月2日。包括比较左心室- ais患者在EVT转院前进行IVT与不进行IVT的研究。疗效结局包括主要功能结局(90天时改良Rankin量表[mRS] 0-1),次要疗效结局包括良好功能结局(90天时mRS 0-2)、医院间再通和较差功能结局(mRS 5-6)。安全性指标包括90天死亡率、症状性颅内出血(sICH)、任何颅内出血(ICH)和实质血肿(PH)。采用随机效应模型计算95%置信区间(ci)的合并优势比(ORs),并采用通用逆方差法综合调整后的估计。结果:纳入16项观察性研究。移植前IVT与良好功能转归率显著升高相关(OR 1.72, 95% CI 1.47-2.01)。结论:在需要院间从PSCs转移到CSCs进行EVT的LVO-AIS患者中,移植前IVT与功能转归改善和院间再通相关,且不增加出血风险。这些发现支持在资源有限且无法立即获得及时EVT的情况下,移植前IVT作为一种有效的再灌注策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neurology
Journal of Neurology 医学-临床神经学
CiteScore
10.00
自引率
5.00%
发文量
558
审稿时长
1 months
期刊介绍: The Journal of Neurology is an international peer-reviewed journal which provides a source for publishing original communications and reviews on clinical neurology covering the whole field. In addition, Letters to the Editors serve as a forum for clinical cases and the exchange of ideas which highlight important new findings. A section on Neurological progress serves to summarise the major findings in certain fields of neurology. Commentaries on new developments in clinical neuroscience, which may be commissioned or submitted, are published as editorials. Every neurologist interested in the current diagnosis and treatment of neurological disorders needs access to the information contained in this valuable journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书